NCT04126044View on ClinicalTrials.gov

A SINGLE-DOSE, 2-ARM, PHARMACOKINETIC STUDY OF PF-06439535 (CN) AND EUROPEAN UNION SOURCED BEVACIZUMAB IN CHINESE HEALTHY MALE VOLUNTEERS

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 22, 2021

Primary Completion Date

July 10, 2021

Study Completion Date

July 10, 2021

Conditions
Pharmacokinetics
Interventions
DRUG

PF-06439535 (CN)

This is the test drug Pfizer biosimilar of bevacizumab-EU.

DRUG

bevacizumab - EU

This is the reference drug bevacizumab sourced from EU

Trial Locations (1)

201107

Huashan Hospital,Fudan University, Shanghai

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04126044 - A SINGLE-DOSE, 2-ARM, PHARMACOKINETIC STUDY OF PF-06439535 (CN) AND EUROPEAN UNION SOURCED BEVACIZUMAB IN CHINESE HEALTHY MALE VOLUNTEERS | Biotech Hunter | Biotech Hunter